KR100752434B1 - Ｒｇ1 폴리펩티드 코딩 폴리뉴클레오티드 - Google Patents

Ｒｇ1 폴리펩티드 코딩 폴리뉴클레오티드 Download PDF

Info

Publication number
KR100752434B1
KR100752434B1 KR1020027007708A KR20027007708A KR100752434B1 KR 100752434 B1 KR100752434 B1 KR 100752434B1 KR 1020027007708 A KR1020027007708 A KR 1020027007708A KR 20027007708 A KR20027007708 A KR 20027007708A KR 100752434 B1 KR100752434 B1 KR 100752434B1
Authority
KR
South Korea
Prior art keywords
polypeptide
seq
amino acid
acid sequence
delete delete
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
KR1020027007708A
Other languages
English (en)
Korean (ko)
Other versions
KR20020065575A (ko
Inventor
리차드 하킨스
데보라 파케스
고든 패리
더글라스 더블유. 슈나이더
레나트 슈타인브레커
Original Assignee
쉐링 악티엔게젤샤프트
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 쉐링 악티엔게젤샤프트 filed Critical 쉐링 악티엔게젤샤프트
Publication of KR20020065575A publication Critical patent/KR20020065575A/ko
Application granted granted Critical
Publication of KR100752434B1 publication Critical patent/KR100752434B1/ko
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4748—Tumour specific antigens; Tumour rejection antigen precursors [TRAP], e.g. MAGE
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Saccharide Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
KR1020027007708A 1999-12-16 2000-12-15 Ｒｇ1 폴리펩티드 코딩 폴리뉴클레오티드 Expired - Fee Related KR100752434B1 (ko)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US17237099P 1999-12-16 1999-12-16
US60/172,370 1999-12-16
US09/732,357 US6682902B2 (en) 1999-12-16 2000-12-07 DNA encoding a novel RG1 polypeptide
US09/732,357 2000-12-07

Publications (2)

Publication Number Publication Date
KR20020065575A KR20020065575A (ko) 2002-08-13
KR100752434B1 true KR100752434B1 (ko) 2007-08-27

Family

ID=26868022

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020027007708A Expired - Fee Related KR100752434B1 (ko) 1999-12-16 2000-12-15 Ｒｇ1 폴리펩티드 코딩 폴리뉴클레오티드

Country Status (32)

Country Link
US (5) US6682902B2 (https=)
EP (2) EP2048157B1 (https=)
JP (1) JP4979867B2 (https=)
KR (1) KR100752434B1 (https=)
CN (1) CN1297566C (https=)
AT (1) ATE440862T1 (https=)
AU (1) AU784674B2 (https=)
BG (1) BG65898B1 (https=)
BR (1) BR0017022A (https=)
CA (1) CA2394574A1 (https=)
CZ (1) CZ299232B6 (https=)
DE (1) DE60042836D1 (https=)
DK (1) DK1237915T3 (https=)
EE (1) EE05293B1 (https=)
ES (1) ES2331106T3 (https=)
HR (1) HRP20020549B1 (https=)
HU (1) HU229001B1 (https=)
IL (2) IL150115A0 (https=)
LT (1) LT5046B (https=)
ME (1) MEP37808A (https=)
MX (1) MXPA02005914A (https=)
NO (1) NO330924B1 (https=)
NZ (1) NZ519598A (https=)
PL (1) PL207634B1 (https=)
PT (1) PT1237915E (https=)
RO (1) RO122543B1 (https=)
RS (1) RS50831B (https=)
RU (1) RU2283130C2 (https=)
SI (2) SI1237915T1 (https=)
SK (2) SK286384B6 (https=)
WO (1) WO2001044291A2 (https=)
ZA (1) ZA200205638B (https=)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1251139A3 (en) * 1998-04-08 2002-12-18 Genentech, Inc. Human mindin-like protein and nucleic acids encoding it
US20020161199A1 (en) * 1998-04-08 2002-10-31 Genentech, Inc. Compositions and methods for the diagnosis and treatment of tumor
US6960433B1 (en) 1998-10-19 2005-11-01 Diadexus, Inc. Method of diagnosing, monitoring, staging, imaging and treating prostate cancer
US20070031901A1 (en) * 1999-03-08 2007-02-08 Genentech, Inc. Compositions and methods for the diagnosis and treatment of tumor
US6682902B2 (en) * 1999-12-16 2004-01-27 Schering Aktiengesellschaft DNA encoding a novel RG1 polypeptide
GT200400138A (es) * 2003-07-22 2005-03-22 Anticuerpos rgi y uso de los mismos.
US7294704B2 (en) * 2003-08-15 2007-11-13 Diadexus, Inc. Pro108 antibody compositions and methods of use and use of Pro108 to assess cancer risk
US7785591B2 (en) 2004-10-14 2010-08-31 Morphosys Ag Identification and characterization of function-blocking anti-ED-B-fibronectin antibodies
TWI596109B (zh) * 2007-02-21 2017-08-21 腫瘤療法 科學股份有限公司 表現腫瘤相關抗原之癌症的胜肽疫苗
BRPI0819765A2 (pt) * 2007-11-30 2015-05-05 Bristol Myers Squibb Co Conjugados de anticorpos anti-rg-1
TW201008574A (en) 2008-08-19 2010-03-01 Oncotherapy Science Inc INHBB epitope peptides and vaccines containing the same
CN102346184B (zh) * 2010-08-03 2014-03-26 中国人民解放军军事医学科学院生物工程研究所 Spon2的新用途
DE102012016127A1 (de) 2011-08-31 2013-02-28 Daniel Elias Bioaktive, regenerative Mischung zur Herstellung eines Ergänzungsnahrungsmittels

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998045442A2 (en) * 1997-04-10 1998-10-15 Zymogenetics, Inc. Secreted f-spondin homologs

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4657760A (en) 1979-03-20 1987-04-14 Ortho Pharmaceutical Corporation Methods and compositions using monoclonal antibody to human T cells
US4683195A (en) 1986-01-30 1987-07-28 Cetus Corporation Process for amplifying, detecting, and/or-cloning nucleic acid sequences
US5206344A (en) 1985-06-26 1993-04-27 Cetus Oncology Corporation Interleukin-2 muteins and polymer conjugation thereof
US4946778A (en) 1987-09-21 1990-08-07 Genex Corporation Single polypeptide chain binding molecules
US5246692A (en) * 1986-09-05 1993-09-21 The United States Of America As Represented By The Secretary Of Health And Human Services Backbone polysubstituted chelates for forming a metal chelate-protein conjugate
US4831175A (en) * 1986-09-05 1989-05-16 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Backbone polysubstituted chelates for forming a metal chelate-protein conjugate
US4987071A (en) 1986-12-03 1991-01-22 University Patents, Inc. RNA ribozyme polymerases, dephosphorylases, restriction endoribonucleases and methods
US5437994A (en) 1989-06-15 1995-08-01 Regents Of The University Of Michigan Method for the ex vivo replication of stem cells, for the optimization of hematopoietic progenitor cell cultures, and for increasing the metabolism, GM-CSF secretion and/or IL-6 secretion of human stromal cells
US5399493A (en) 1989-06-15 1995-03-21 The Regents Of The University Of Michigan Methods and compositions for the optimization of human hematopoietic progenitor cell cultures
US5225212A (en) 1989-10-20 1993-07-06 Liposome Technology, Inc. Microreservoir liposome composition and method
US6150584A (en) * 1990-01-12 2000-11-21 Abgenix, Inc. Human antibodies derived from immunized xenomice
US5877397A (en) 1990-08-29 1999-03-02 Genpharm International Inc. Transgenic non-human animals capable of producing heterologous antibodies of various isotypes
ATE300615T1 (de) 1990-08-29 2005-08-15 Genpharm Int Transgene mäuse fähig zur produktion heterologer antikörper
JPH08502950A (ja) 1992-05-14 1996-04-02 リボザイム・ファーマシューティカルズ・インコーポレイテッド 癌増殖を抑制する方法及び試薬
US5871969A (en) 1996-02-12 1999-02-16 Human Genome Sciences, Inc. Nucleic acids encoding human neuronal attachment factor-1
US6287777B1 (en) * 1996-05-10 2001-09-11 Beth Israel Deaconess Medical Center NPG-1 gene that is differentially expressed in prostate tumors
US6177244B1 (en) * 1996-05-10 2001-01-23 Beth Israel Deaconess Medical Center Inc. NPG-1 gene that is differentially expressed in prostate tumors
US5804382A (en) 1996-05-10 1998-09-08 Beth Israel Deaconess Medical Center, Inc. Methods for identifying differentially expressed genes and differences between genomic nucleic acid sequences
JP3494529B2 (ja) * 1996-06-06 2004-02-09 Ｙｋｋ株式会社 一体成形面ファスナー
EP0933994A4 (en) * 1996-08-26 2002-09-18 Univ Washington THERAPEUTIC AND DIAGNOSTIC APPLICATIONS OF SPLICE VARIANTS OF THE PERLECAN I AREA
CA2289116A1 (en) * 1997-05-06 1998-11-12 Human Genome Sciences, Inc. Enterococcus faecalis polynucleotides and polypeptides
JP2001500386A (ja) 1997-05-09 2001-01-16 スミスクライン ビーチャム コーポレーション インテグリンリガンドであるヒトＭｉｎｄｉｎ
JP3868740B2 (ja) 1998-03-10 2007-01-17 ジェネンテック・インコーポレーテッド 新規なポリペプチド及びそれをコードする核酸
US6166176A (en) * 1998-03-17 2000-12-26 Immvarx, Inc. Cancer marker protein and peptides thereof
US6960433B1 (en) * 1998-10-19 2005-11-01 Diadexus, Inc. Method of diagnosing, monitoring, staging, imaging and treating prostate cancer
EP1126877A4 (en) * 1998-10-19 2003-05-28 Diadexus Inc METHOD OF DIAGNOSIS, MONITORING, STADIUM CLASSIFICATION, VISUALIZATION AND TREATMENT OF PROSTATE CANCER
US6682736B1 (en) * 1998-12-23 2004-01-27 Abgenix, Inc. Human monoclonal antibodies to CTLA-4
US6824780B1 (en) * 1999-10-29 2004-11-30 Genentech, Inc. Anti-tumor antibody compositions and methods of use
US6682902B2 (en) * 1999-12-16 2004-01-27 Schering Aktiengesellschaft DNA encoding a novel RG1 polypeptide

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998045442A2 (en) * 1997-04-10 1998-10-15 Zymogenetics, Inc. Secreted f-spondin homologs

Also Published As

Publication number Publication date
EP2048157B1 (en) 2012-10-10
CA2394574A1 (en) 2001-06-21
HU229001B1 (en) 2013-07-29
HUP0204224A2 (hu) 2003-03-28
IL150115A (en) 2013-11-28
NO330924B1 (no) 2011-08-22
BG106823A (bg) 2003-04-30
HRP20020549B1 (hr) 2013-09-30
RO122543B1 (ro) 2009-08-28
BR0017022A (pt) 2002-11-05
CZ299232B6 (cs) 2008-05-21
SK288147B6 (sk) 2013-12-02
SI1237915T1 (sl) 2009-12-31
US7893217B2 (en) 2011-02-22
EP1237915A2 (en) 2002-09-11
PL207634B1 (pl) 2011-01-31
US20090214422A1 (en) 2009-08-27
LT5046B (lt) 2003-08-25
EP1237915B1 (en) 2009-08-26
WO2001044291A2 (en) 2001-06-21
PL356220A1 (en) 2004-06-28
RU2002119208A (ru) 2004-02-27
US7307154B2 (en) 2007-12-11
HUP0204224A3 (en) 2004-12-28
US20020004047A1 (en) 2002-01-10
RU2283130C2 (ru) 2006-09-10
SK286384B6 (sk) 2008-08-05
ZA200205638B (en) 2003-10-15
US20040023307A1 (en) 2004-02-05
DK1237915T3 (da) 2009-11-16
YU44602A (sh) 2005-06-10
NO20022836D0 (no) 2002-06-14
DE60042836D1 (de) 2009-10-08
ATE440862T1 (de) 2009-09-15
NO20022836L (no) 2002-08-15
EP2048157A1 (en) 2009-04-15
US20090292112A1 (en) 2009-11-26
SI21140A (sl) 2003-08-31
CN1434832A (zh) 2003-08-06
BG65898B1 (bg) 2010-04-30
KR20020065575A (ko) 2002-08-13
AU3074601A (en) 2001-06-25
SK8482002A3 (en) 2003-02-04
US20040152139A1 (en) 2004-08-05
EE200200323A (et) 2003-10-15
IL150115A0 (en) 2002-12-01
EE05293B1 (et) 2010-04-15
CN1297566C (zh) 2007-01-31
US6682902B2 (en) 2004-01-27
JP4979867B2 (ja) 2012-07-18
HRP20020549A2 (en) 2004-04-30
MXPA02005914A (es) 2003-02-27
WO2001044291A3 (en) 2002-01-17
MEP37808A (en) 2011-05-10
LT2002070A (en) 2003-04-25
JP2003521244A (ja) 2003-07-15
NZ519598A (en) 2004-03-26
PT1237915E (pt) 2009-11-04
RS50831B (sr) 2010-08-31
AU784674B2 (en) 2006-05-25
ES2331106T3 (es) 2009-12-22
US7887804B2 (en) 2011-02-15

Similar Documents

Publication Publication Date Title
US7893217B2 (en) Isolated human antibodies that bind epitopes on RG1
US20020009455A1 (en) DNA encoding a novel PROST 03 polypeptide
JP2003528584A (ja) Ｐｒｏｓｔ０７ポリペプチドをコードするｄｎａ
JP2003533177A (ja) 新規ＰＲＯＳＴ−ＥｔｓポリペプチドをコードするＤＮＡ

Legal Events

Date Code Title Description
PA0105 International application

St.27 status event code: A-0-1-A10-A15-nap-PA0105

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

A201 Request for examination
P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

E13-X000 Pre-grant limitation requested

St.27 status event code: A-2-3-E10-E13-lim-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

St.27 status event code: A-1-2-D10-D22-exm-PE0701

GRNT Written decision to grant
PR0701 Registration of establishment

St.27 status event code: A-2-4-F10-F11-exm-PR0701

PR1002 Payment of registration fee

St.27 status event code: A-2-2-U10-U12-oth-PR1002

Fee payment year number: 1

PG1601 Publication of registration

St.27 status event code: A-4-4-Q10-Q13-nap-PG1601

PN2301 Change of applicant

St.27 status event code: A-5-5-R10-R13-asn-PN2301

St.27 status event code: A-5-5-R10-R11-asn-PN2301

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 4

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 5

R18-X000 Changes to party contact information recorded

St.27 status event code: A-5-5-R10-R18-oth-X000

FPAY Annual fee payment

Payment date: 20120802

Year of fee payment: 6

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 6

FPAY Annual fee payment

Payment date: 20130801

Year of fee payment: 7

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 7

LAPS Lapse due to unpaid annual fee
PC1903 Unpaid annual fee

St.27 status event code: A-4-4-U10-U13-oth-PC1903

Not in force date: 20140821

Payment event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

PC1903 Unpaid annual fee

St.27 status event code: N-4-6-H10-H13-oth-PC1903

Ip right cessation event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

Not in force date: 20140821